Telithromycin and Myasthenia Gravis

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2003-12, Vol.37 (11), p.1579-1579
Main Authors: Nieman, Richard B., Sharma, Kristen, Edelberg, Helen, Caffe, Steve E.
Format: Article
Language:English
Subjects:
Correspondence
Drug Approval - organization & administration
Drug Monitoring
Humans
Ketolides
Macrolides - adverse effects
Myasthenia gravis
Myasthenia Gravis - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c392t-c540cd18f6e95ed04d287fa01c99420a7dbfec18d8b454e08971180ad1967d1a3
cites cdi_FETCH-LOGICAL-c392t-c540cd18f6e95ed04d287fa01c99420a7dbfec18d8b454e08971180ad1967d1a3
container_end_page 1579
container_issue 11
container_start_page 1579
container_title Clinical infectious diseases
container_volume 37
creator Nieman, Richard B.
Sharma, Kristen
Edelberg, Helen
Caffe, Steve E.
description
doi_str_mv 10.1086/379617
format article
fullrecord <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1086_379617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4483738</jstor_id><oup_id>10.1086/379617</oup_id><sourcerecordid>4483738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-c540cd18f6e95ed04d287fa01c99420a7dbfec18d8b454e08971180ad1967d1a3</originalsourceid><addsrcrecordid>eNp1kFtLAzEQhYMotlb9BSIVwbfVzOb-WKp2hXp5qBd8CWmSpVvbbkm2Yv-9W7bUJ2FgBs7HYc5B6BTwNWDJb4hQHMQeagMjIuFMwX59YyYTKolsoaMYpxgDSMwOUQsor0eSNroc-VlRTUI5X9ti0TUL131cm1hN_KIw3UEw30U8Rge5mUV_st0d9Hp_N-pnyfB58NDvDRNLVFolllFsHcice8W8w9SlUuQGg1WKptgIN869BenkmDLqsVRi849xoLhwYEgHXTW-NpQxBp_rZSjmJqw1YL1JqZuUNXjegMvVeO7dH7aNVQMXDVCulv-bnDXMNFZl2FG07ksQWctJIxex8j872YQvzQURTGcfn_r2KXt_IVzpN_ILOTVtTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Telithromycin and Myasthenia Gravis</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford Journals Online</source><creator>Nieman, Richard B. ; Sharma, Kristen ; Edelberg, Helen ; Caffe, Steve E.</creator><creatorcontrib>Nieman, Richard B. ; Sharma, Kristen ; Edelberg, Helen ; Caffe, Steve E.</creatorcontrib><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/379617</identifier><identifier>PMID: 14614683</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Correspondence ; Drug Approval - organization &amp; administration ; Drug Monitoring ; Humans ; Ketolides ; Macrolides - adverse effects ; Myasthenia gravis ; Myasthenia Gravis - complications</subject><ispartof>Clinical infectious diseases, 2003-12, Vol.37 (11), p.1579-1579</ispartof><rights>Copyright 2003 The Infectious Diseases Society of America</rights><rights>2003 by the Infectious Diseases Society of America 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-c540cd18f6e95ed04d287fa01c99420a7dbfec18d8b454e08971180ad1967d1a3</citedby><cites>FETCH-LOGICAL-c392t-c540cd18f6e95ed04d287fa01c99420a7dbfec18d8b454e08971180ad1967d1a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4483738$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4483738$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,778,782,27907,27908,58221,58454</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14614683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nieman, Richard B.</creatorcontrib><creatorcontrib>Sharma, Kristen</creatorcontrib><creatorcontrib>Edelberg, Helen</creatorcontrib><creatorcontrib>Caffe, Steve E.</creatorcontrib><title>Telithromycin and Myasthenia Gravis</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><subject>Correspondence</subject><subject>Drug Approval - organization &amp; administration</subject><subject>Drug Monitoring</subject><subject>Humans</subject><subject>Ketolides</subject><subject>Macrolides - adverse effects</subject><subject>Myasthenia gravis</subject><subject>Myasthenia Gravis - complications</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp1kFtLAzEQhYMotlb9BSIVwbfVzOb-WKp2hXp5qBd8CWmSpVvbbkm2Yv-9W7bUJ2FgBs7HYc5B6BTwNWDJb4hQHMQeagMjIuFMwX59YyYTKolsoaMYpxgDSMwOUQsor0eSNroc-VlRTUI5X9ti0TUL131cm1hN_KIw3UEw30U8Rge5mUV_st0d9Hp_N-pnyfB58NDvDRNLVFolllFsHcice8W8w9SlUuQGg1WKptgIN869BenkmDLqsVRi849xoLhwYEgHXTW-NpQxBp_rZSjmJqw1YL1JqZuUNXjegMvVeO7dH7aNVQMXDVCulv-bnDXMNFZl2FG07ksQWctJIxex8j872YQvzQURTGcfn_r2KXt_IVzpN_ILOTVtTg</recordid><startdate>200312</startdate><enddate>200312</enddate><creator>Nieman, Richard B.</creator><creator>Sharma, Kristen</creator><creator>Edelberg, Helen</creator><creator>Caffe, Steve E.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200312</creationdate><title>Telithromycin and Myasthenia Gravis</title><author>Nieman, Richard B. ; Sharma, Kristen ; Edelberg, Helen ; Caffe, Steve E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-c540cd18f6e95ed04d287fa01c99420a7dbfec18d8b454e08971180ad1967d1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Correspondence</topic><topic>Drug Approval - organization &amp; administration</topic><topic>Drug Monitoring</topic><topic>Humans</topic><topic>Ketolides</topic><topic>Macrolides - adverse effects</topic><topic>Myasthenia gravis</topic><topic>Myasthenia Gravis - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nieman, Richard B.</creatorcontrib><creatorcontrib>Sharma, Kristen</creatorcontrib><creatorcontrib>Edelberg, Helen</creatorcontrib><creatorcontrib>Caffe, Steve E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nieman, Richard B.</au><au>Sharma, Kristen</au><au>Edelberg, Helen</au><au>Caffe, Steve E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Telithromycin and Myasthenia Gravis</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2003-12</date><risdate>2003</risdate><volume>37</volume><issue>11</issue><spage>1579</spage><epage>1579</epage><pages>1579-1579</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>14614683</pmid><doi>10.1086/379617</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2003-12, Vol.37 (11), p.1579-1579
issn 1058-4838
1537-6591
language eng
recordid cdi_crossref_primary_10_1086_379617
source JSTOR Archival Journals and Primary Sources Collection; Oxford Journals Online
subjects Correspondence
Drug Approval - organization & administration
Drug Monitoring
Humans
Ketolides
Macrolides - adverse effects
Myasthenia gravis
Myasthenia Gravis - complications
title Telithromycin and Myasthenia Gravis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T00%3A43%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Telithromycin%20and%20Myasthenia%20Gravis&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Nieman,%20Richard%20B.&rft.date=2003-12&rft.volume=37&rft.issue=11&rft.spage=1579&rft.epage=1579&rft.pages=1579-1579&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/379617&rft_dat=%3Cjstor_cross%3E4483738%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-c540cd18f6e95ed04d287fa01c99420a7dbfec18d8b454e08971180ad1967d1a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/14614683&rft_jstor_id=4483738&rft_oup_id=10.1086/379617&rfr_iscdi=true